Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada-Reference-Cited by-同舟云学术

Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada

Published:2023-04 Issue: Volume:115 Page:102526
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Wong Jason K.,Lim Howard J.,Tam Vincent C.,Burak Kelly W.,Dawson Laura A.,Chaudhury Prosanto,Abraham Robert J.,Meyers Brandon M.,Sapisochin Gonzalo,Valenti David,Samimi Setareh,Ramjeesingh Ravi,Mujoomdar Amol,Martins Ilidio,Dixon Elijah,Segedi Maja,Liu David M.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference353 articles.

1. The changing epidemiology of primary liver cancer;Petrick;Curr Epidemiol Rep,2019

2. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Multidisciplinary management of patients with unresectable hepatocellular carcinoma: a critical appraisal of current evidence;Gholam;Cancers (Basel),2019

4. Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma;Ho;Sci Rep,2020

5. Hepatocellular carcinoma;Villanueva;N Engl J Med,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis;Frontiers in Immunology;2024-08-02

2. The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review;Cancer Treatment Reviews;2023-07